|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/38 | (2006.01) |
| (11) | Number of the document | 2945647 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14741142.5 |
| Date of filing the European patent application | 2014-01-15 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation | 2021-02-25 |
| (86) | Number | PCT/US2014/011711 |
| Date | 2014-01-15 |
| (87) | Number | WO 2014/113490 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| 201361752799 P | 2013-01-15 | US |
| (72) |
SCHEINBERG, David A., US
DAO, Tao, US
|
| (73) |
Memorial Sloan Kettering Cancer Center,
1275 York Avenue, New York, NY 10021,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Imunogeniniai WT-1 peptidai ir jų panaudojimo būdai |
| IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-11-21 | 13 | 289.00 EUR |
| 2027-01-15 |